Trial Profile
A randomized, parallel CO2 laser-controlled, multi-center trial of Aminolevulinic-acid in patients with condyloma acuminatum
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Aug 2015
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Condylomata acuminata
- Focus Therapeutic Use
- Sponsors Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
- 18 Aug 2015 Results published in Shanghai Fudan-Zhangjiang Bio-Pharmaceutical website.
- 18 Aug 2015 New trial record